Found 157 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is S  [Clear All Filters]
2012
G. Mutua, Sanders, E., Mugo, P., Anzala, O., Haberer, J. E., Bangsberg, D., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers, PLoS One, vol. 7, p. e33103, 2012.
M. Cohen-Wolkowiez, Poindexter, B., Bidegain, M., Weitkamp, J. - H., Schelonka, R. L., Randolph, D. A., Ward, R. M., Wade, K., Valencia, G., Burchfield, D., Arrieta, A., Mehta, V., Walsh, M., Kantak, A., Rasmussen, M., Sullivan, J. E., Finer, N., Rich, W., Brozanski, B. S., van den Anker, J., Blumer, J., Laughon, M., Watt, K. M., Kearns, G. L., Capparelli, E. V., Martz, K., Berezny, K., Benjamin, D. K., and P Smith, B., Safety and Effectiveness of Meropenem in Infants with Suspected or Complicated Intra-Abdominal Infections, Clin Infect Dis, vol. 55, no. 11, pp. 1495-1502, 2012.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, J Infect Dis, vol. 206, pp. 828-837, 2012.
F. A. Folgar, Chow, J. H., Farsiu, S., Wong, W. T., Schuman, S. G., O'Connell, R. V., Winter, K. P., Chew, E. Y., Hwang, T. S., Srivastava, S. K., Harrington, M. W., Clemons, T. E., and Toth, C. A., Spatial Correlation Between Hyperpigmentary Changes on Color Fundus Photography and Hyperreflective Foci on SDOCT in Intermediate AMD, Invest Ophthalmol Vis Sci, vol. 53, pp. 4626-4633, 2012.
D. M. Donovan, Bogenschutz, M. P., Perl, H., Forcehimes, A., Adinoff, B., Mandler, R., Oden, N., and Walker, R., Study Design to Examine the Potential Role of Assessment Reactivity in Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED) Protocol, Addict Sci Clin Pract, vol. 7, p. 16, 2012.
D. M. Fleischer, Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A., Mayer, L., Lindblad, R., and Sampson, H. A., Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial, in AAAAI - American Academy of Allergy, Asthma & Immunology, 2012, vol. 129(2), p. AB66.
J. Robinson-Papp, Gelman, B., Grant, I., Singer, E., Gensler, G., and Morgello, S., Substance Abuse Increases the Risk of Neuropathy in an HIV-Infected Cohort, Muscle & Nerve, vol. 45, no. 4, pp. 471-476, 2012.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S., Hanto, D., Light, J., Bartlett, S., Tzakis, A., Pearson, T., Barin, B., Roland, M., and Stock, P., Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients, Surgery, vol. 152, pp. 376-381, 2012.
2011
P. Pitisuttithum, Rerks-Ngarm, S., Bussaratid, V., Dhitavat, J., Maekanantawat, W., Pungpak, S., Suntharasamai, P., Vanijanonta, S., Nitayapan, S., Kaewkungwal, J., Benenson, M., Morgan, P., O'Connell, R., Berenberg, J., Francis, D., ,, Stablein, D., and , Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand, PLoS One, vol. 6, p. e27837, 2011.
C. Chan, Ip, M., Van Veldhuisen, P., Oden, N., Scott, I., Tolentino, M., and Blodi, B., SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion, Ophthalmology, vol. 118, pp. 1364-1372, 2011.
T. Whiteside, Griffin, D., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D., Shipping of Therapeutic Somatic Cell Products, Cytotherapy, vol. 13, pp. 201-213, 2011.
P. B. Gilbert, Berger, J. O., Stablein, D., Becker, S., Essex, M., Hammer, S. M., Kim, J. H., and Degruttola, V. G., Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: a Case Study for Statistical Issues in Efficacy Trials, J Infect Dis, vol. 203, pp. 969-975, 2011.
M. Trivedi, Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Warden, D., Ring, K., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, B., Oden, N., and Nunes, E., Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial, Trials, vol. 19, pp. 206-231, 2011.
R. Lindblad, Campanella, M., Styers, D., Kothari, P., Sparenborg, S., and Rosa, C., Strategies for Safety Reporting in Substance Abuse Trials, Am J Drug Alcohol Abuse, vol. 37, no. 5, pp. 440-445, 2011.
T. McLellan, Tai, B., and Gore-Langton, R., Symposium: CTN Electronic Medical Records Project - Implication of Adopting Standardized Core-Date Elements in Health IT Systems of Drug Abuse Treatment Providers, in American Psychological Association (APA) 119th Convention, Washington, DC, 2011.
2010
E. H Sahly, Patel, S., Atmar, R., Lanford, T., Dube, T., Thompson, D., Sim, B. K., Long, C., and Keitel, W., Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria is Not Endemic, Clinical and Vaccine Immunology, vol. 17, pp. 1552-1559, 2010.
M. Thera, Doumbo, O., Coulibaly, D., Laurens, M., Kone, A., Guindo, A., Traore, K., Sissoko, M., Diallo, D., Diarra, I., Kouriba, B., Daou, M., Dolo, A., Baby, M., Sissoko, M., Sagara, I., Niangaly, A., Traore, I., Olotu, A., Godeaux, O., Leach, A., Dubois, M., and Ballou, W., Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial, PLoS One, vol. 5, p. e9041, 2010.
S. Frey, Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A., Rinella, P., Hill, H., Wolff, M., Schultze, V., Han, J., Scharschmidt, B., and Belshe, R., Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults, Vaccine, vol. 28, pp. 6367-6373, 2010.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
S. Gilmour, Sorensen, L., Anand, R., Yin, W., Alonso, E., and Consortium, T. Studies fo, School Outcomes in Children Registered in The Studies for Pediatric Liver Transplant (SPLIT) Consortium, Liver Transpl, vol. 16, pp. 1041-1048, 2010.
N. Oden, Van Veldhuisen, P., Scott, I., and Ip, M., SCORE Study Report 8: Closed Tests for All Pairwise Comparisons of Means, Drug Inf J, vol. 44, pp. 405-420, 2010.